Advocacy Center

CONGRESSIONAL TESTIMONY

Each year, AAI submits written testimony to the House and Senate subcommittees that fund NIH. Among other things, these testimonies include an NIH funding request and highlight important immunologic discoveries.

LETTERS AND COMMENTS

The AAI Committee on Public Affairs communicates the policy positions of AAI through letters to legislators, government officials/agencies, and other organizations that have an impact on biomedical research.

  • AAI submits letter to key House leaders strongly opposing elimination of the tuition waiver tax exemption for graduate students (11/13/17)
  • AAI submits letter to NIH regarding its proposed Grant Support Index (05/31/17)
  • AAI provides written testimony to the Senate Labor-HHS Appropriations Subcommittee on FY 2018 funding for NIH (05/25/17)
  • AAI signs multi-organization letter to congressional leaders urging them to reject President Trump’s proposed cuts to science (05/24/17)
  • AAI issues statement opposing President Trump’s proposed FY 2018 NIH budget cut (03/24/17)
  • AAI provides written testimony to the House Labor-HHS Appropriations Subcommittee on FY 2018 funding for NIH (3/6/17)
  • AAI joins community letter to President Trump supporting vaccine safety (02/07/17)
  • AAI President Arlene Sharpe releases message to members on issues of national concern (02/01/17)
  • AAI signs multi-society letter on White House Executive Order on immigration and visas (01/31/17)
2016 Letters and Comments
  • AAI submits comments to NIH regarding the use of interim research products (12/6/16)
  • AAI sends letter to Representatives Upton and DeGette regarding the 21st Century Cures Act (11/29/16)
  • AAI provides written testimony to the House Labor-HHS Appropriations Subcommittee on FY 2017 funding for NIH (4/11/16)
  • AAI provides written testimony to the Senate Labor-HHS Appropriations Subcommittee on FY 2017 funding for NIH (4/11/16)
  • AAI submits comments to NSABB regarding its draft recommendations for gain-of-function research studies (3/08/16)
2015 Letters and Comments
  • AAI submits letter to Senator Cassidy expressing concern about efforts to legislate the re-allocation of funding within the NIH portfolio (12/4/15)
  • AAI submits comments on simplifying NIH grant application instructions (9/22/15)
  • AAI comments on proposed changes to the Animal Welfare Act Regulations (8/21/15)
  • AAI submits comments to NIH on its framework for a strategic plan (8/14/15)
  • AAI responds to APHIS Notice of Petition on defining alternatives in animal research (5/28/15)
  • AAI submits comments to USDA request for information on reducing regulatory burdens (5/18/15)
  • AAI responds to NIH Request for Information on optimizing funding policies to improve the impact and sustainability of biomedical research (5/15/15)
  • AAI letter to Senator Durbin endorsing the American Cures Act (3/9/15)
  • AAI letter to Senator Mikulski endorsing the Accelerating Biomedical Research Act (3/9/15)
  • AAI letter to Representatives DeLauro and Higgins endorsing the Accelerating Biomedical Research Act (3/9/15)
  • AAI issues statement in strong support of routine and seasonal vaccinations (3/6/15)
  • AAI submits comments to NIH on a proposed Emeritus Award for senior investigators (3/6/15)
2014 Letters and Comments
  • AAI responds to NIH Request for Information on reagent-related barriers to reproducibility (12/19/14)
  • AAI letter to NIH regarding the BRAIN Initiative (10/15/14)
  • AAI letter to Representatives DeLauro and Higgins endorsing the Accelerating Biomedical Research Act (9/23/14)
  • AAI letter to Representatives Smith and Bass on the Ebola epidemic (9/15/14)
  • AAI letter to Senators Harkin, Alexander, and Moran, on the Ebola epidemic (9/12/14)
  • AAI statement on the Ebola epidemic (9/12/2014)
  • AAI letter to Senator Harkin endorsing the Accelerating Biomedical Research Act (8/4/2014)
  • AAI letter to Senators Carper and Coburn in opposition to the Conference Accountability Act (7/29/14)
  • AAI letter to the NIH Office of Laboratory Animal Welfare in response to its Proposed Guidance Regarding Significant Changes to Ongoing Animal Activities (5/12/14)
  • AAI letter to Senator Durbin endorsing the American Cures Act (3/10/14)
  • AAI submits testimony to the Senate Committee on Homeland Security and Governmental Affairs regarding federal spending on conference and travel (for the hearing record of 01/14/14)

ADVOCACY RESOURCES

Interested in communicating the value of immunology and biomedical research to policymakers?  These resources will help you do just that. 

  • Sign up for e-action alerts to receive email notifications about key issues and step-by-step instructions on how to make your voice heard
  • Locate and contact your Congressional Representatives
  • State and District NIH factsheets
  • Federal Funding Report
  • Handout: “The Value of Federally Funded Biomedical & Biological Research”
  • Factsheet: “Animal Research Saves Lives”

VISIT CAPITOL HILL WITH AAI

AAI is happy to take AAI members to Capitol Hill to advocate for NIH and biomedical research.  If you are going to be in the Washington, D.C., area, contact us to let us know that you are interested in meeting with your Congressional delegation.

Step 1: Contact Manager, Science Policy and Legislative Affairs Jake Schumacher (jschumacher@aai.org) and let him know that you would like to go to Capitol Hill and the dates you are available. (AAI will be in touch with you to schedule a mutually agreeable date)

Step 2: AAI will contact your Congressional delegation and schedule your meetings.

Step 3: AAI will put together everything you need for a successful Hill visit, including talking points and items to hand out to the offices you visit.

Step 4: AAI Director of Public Policy and Government Affairs Lauren Gross will escort you to your appointments and help guide you through your meetings.

It’s that simple!

WORKING WITH FASEB

AAI works both independently and closely with the Federation of American Societies For Experimental Biology (FASEB) to advance biomedical research, immunology, and the interests of AAI members.

AAI is a charter member of FASEB. FASEB has 31 member societies and represents more than 125,000 researchers.

AAI Representative to the FASEB Board (2017 – 2018)

  • Louis Justement, Ph.D., Professor of Microbiology, University of Alabama at Birmingham School of Medicine

AAI Members Serving on FASEB Board Standing Committees and Subcommittees (2017 – 2018)

  • Gyorgy Abel, M.D., Ph.D., Science Policy Committee (SPC) Subcommittee on Clinical and Translational Research
  • Gail Bishop, Ph.D., SPC Subcommittee on Research Enterprise Evaluation
  • Cherié Butts, Ph. D., Finance Committee
  • David Chaplin, M.D., Ph.D., AAI Representative to the SPC; SPC Subcommittee on Clinical and Translational Research; SPC Subcommittee on Shared Research Resources
  • M. Michele Hogan, Ph.D. (AAI Executive Director), Executive Officers Advisory Committee
  • Louis Justement, Ph.D., Chair, SPC Subcommittee on Training and Career Opportunities
  • Virginia Shapiro, Ph.D., Excellence in Science Award Committee

AAI CAPITOL HILL PHOTO GALLERY

Photo-4
Photo-5
Photo-6
Photo-7
Photo-8
Photo-9